HK1004368A1 - Pharmaceutical composition for topical application containing acyclovir and hydrocortisone - Google Patents

Pharmaceutical composition for topical application containing acyclovir and hydrocortisone

Info

Publication number
HK1004368A1
HK1004368A1 HK98103634A HK98103634A HK1004368A1 HK 1004368 A1 HK1004368 A1 HK 1004368A1 HK 98103634 A HK98103634 A HK 98103634A HK 98103634 A HK98103634 A HK 98103634A HK 1004368 A1 HK1004368 A1 HK 1004368A1
Authority
HK
Hong Kong
Prior art keywords
hydrocortisone
pharmaceutical composition
topical application
application containing
containing acyclovir
Prior art date
Application number
HK98103634A
Other languages
English (en)
Inventor
Johan Georg Harmenberg
Ann Harriet Marg Kristofferson
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of HK1004368A1 publication Critical patent/HK1004368A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HK98103634A 1995-02-06 1998-04-29 Pharmaceutical composition for topical application containing acyclovir and hydrocortisone HK1004368A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500114 1995-02-06
PCT/SE1996/000124 WO1996024355A1 (en) 1995-02-06 1996-02-02 Novel pharmaceutical combination

Publications (1)

Publication Number Publication Date
HK1004368A1 true HK1004368A1 (en) 1998-11-27

Family

ID=20396821

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103634A HK1004368A1 (en) 1995-02-06 1998-04-29 Pharmaceutical composition for topical application containing acyclovir and hydrocortisone

Country Status (30)

Country Link
US (2) USRE39264E1 (xx)
EP (2) EP1419803B1 (xx)
JP (2) JP4260220B2 (xx)
KR (1) KR100431042B1 (xx)
CN (1) CN1131034C (xx)
AR (1) AR002030A1 (xx)
AT (2) ATE262907T1 (xx)
AU (1) AU716809B2 (xx)
CA (1) CA2211389C (xx)
DE (3) DE69632034T2 (xx)
DK (1) DK0809498T3 (xx)
DZ (1) DZ1966A1 (xx)
ES (1) ES2214528T3 (xx)
FI (1) FI119415B (xx)
FR (1) FR10C0038I2 (xx)
HK (1) HK1004368A1 (xx)
HR (1) HRP960034B1 (xx)
IL (1) IL116913A0 (xx)
MA (1) MA23800A1 (xx)
MY (1) MY119365A (xx)
NO (1) NO314220B1 (xx)
NZ (1) NZ301407A (xx)
PT (1) PT809498E (xx)
SA (1) SA96160590B1 (xx)
SI (1) SI0809498T1 (xx)
TN (1) TNSN96024A1 (xx)
TW (1) TW438585B (xx)
WO (1) WO1996024355A1 (xx)
YU (1) YU49477B (xx)
ZA (1) ZA96527B (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
SE9803929D0 (sv) * 1998-11-18 1998-11-18 Medivir Ab Antiviral formulation
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
CA2537185A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7618950B2 (en) * 2004-07-07 2009-11-17 Arigen Pharmaceuticals, Inc. Method for treatment and prevention of herpes zoster by topical application
WO2006105216A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
CA2604392A1 (en) * 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
WO2008051186A2 (en) * 2005-08-09 2008-05-02 Nanobio Corporation Nanoemulsion containing compositions having ant i -inflammatory activity
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US7797337B2 (en) * 2005-09-29 2010-09-14 Scenera Technologies, Llc Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
JP2009512677A (ja) * 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ホスホジエステラーゼタイプｉｖ阻害剤の組成物
FR2900577B1 (fr) * 2006-05-04 2008-09-12 Goemar Lab Sa Nouveaux medicaments pour les traitements contre le virus de l'herpes
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
CA2680625C (en) 2007-03-14 2016-02-23 Ranbaxy Laboratories Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2155209A4 (en) * 2007-04-26 2012-06-13 Univ Pennsylvania DNA polymerase inhibitor composition and method
US8747872B2 (en) 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US20090291895A1 (en) * 2008-05-23 2009-11-26 Wong Scott W Methods and Compositions for the Treatment of Inflammatory Diseases
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
CN102049050B (zh) * 2009-11-02 2014-06-18 重庆华邦制药有限公司 抗疱疹病毒感染的药物组合物
EP2489354A1 (en) 2011-02-18 2012-08-22 Vironova AB Pharmaceutical formulation of B220 for topical treatment of herpes
ITMI20111747A1 (it) * 2011-09-28 2013-03-29 Fidia Farmaceutici Composizioni farmaceutiche topiche comprendenti aciclovir
FR2983731B1 (fr) * 2011-12-07 2014-04-25 Univ Paris Descartes Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
WO2014159731A1 (en) * 2013-03-13 2014-10-02 Nal Pharmaceuticals, Ltd A topical antiviral composition containing a local anesthetic and method of making the same
CN104324039A (zh) * 2014-10-20 2015-02-04 付茜 一种治疗人身体表面脂肪瘤的药剂及使用方法
CN108853140A (zh) * 2018-07-18 2018-11-23 豆立忠 一种多药物模块软膏及其制备方法
WO2020036545A1 (en) * 2018-08-17 2020-02-20 İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. Phase stable topical composition comprising acyclovir and hydrocortisone
KR20220020911A (ko) 2019-06-14 2022-02-21 프로펠라 쎄라퓨틱스, 인크. 국소 아시클로버 제형 및 이의 용도
CN112569243A (zh) * 2019-09-30 2021-03-30 神农医药科技有限公司 制备治疗阿尔茨海默病的药物
KR20230024280A (ko) * 2020-05-11 2023-02-20 르비어, 인크. 바이러스 감염을 치료하기 위한 조성물 및 방법(compositions and methods for treating viral infections)
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏
US11951082B2 (en) * 2022-08-22 2024-04-09 Ford Therapeutics, Llc Composition of chlorhexidine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4610868A (en) 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0594223B1 (en) * 1985-09-17 2000-03-01 The Wellcome Foundation Limited Combination of therapeutic nucleosides and further therapeutic agents.
US4942031A (en) 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
US5023090A (en) 1989-08-16 1991-06-11 Levin Robert H Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
WO1990006775A1 (en) * 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
AU636255B2 (en) * 1990-11-05 1993-04-22 Arthropharm Pty Ltd Use of a topical formulation for the treatment of viral infections and neoplastic disorders
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
AU666852B2 (en) 1991-05-01 1996-02-29 Henry M. Jackson Foundation For The Advancement Of Military Medicine A method for treating infectious respiratory diseases
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
DZ1965A1 (fr) * 1995-02-06 2002-07-17 Astra Ab Composition pharmaceutique nouvelle.
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
HRP960034A2 (en) 1997-10-31
YU49477B (sh) 2006-05-25
EP1419803A2 (en) 2004-05-19
JP2007284452A (ja) 2007-11-01
JP4260220B2 (ja) 2009-04-30
FI973243A0 (fi) 1997-08-06
NO314220B1 (no) 2003-02-17
TW438585B (en) 2001-06-07
AR002030A1 (es) 1998-01-07
SA96160590B1 (ar) 2005-10-05
EP0809498A1 (en) 1997-12-03
SI0809498T1 (en) 2004-12-31
CN1131034C (zh) 2003-12-17
ZA96527B (en) 1996-08-06
JPH11506417A (ja) 1999-06-08
FR10C0038I2 (xx) 2011-04-29
FR10C0038I1 (xx) 2010-10-15
FI119415B (fi) 2008-11-14
CA2211389A1 (en) 1996-08-15
IL116913A0 (en) 1996-05-14
DK0809498T3 (da) 2004-05-10
CA2211389C (en) 2007-11-20
HRP960034B1 (en) 2002-02-28
ES2214528T3 (es) 2004-09-16
EP1419803A3 (en) 2004-06-09
US6337324B1 (en) 2002-01-08
WO1996024355A1 (en) 1996-08-15
DZ1966A1 (fr) 2002-10-15
TNSN96024A1 (fr) 2005-03-15
FI973243A (fi) 1997-08-06
DE122010000032I1 (de) 2010-10-21
EP1419803B1 (en) 2009-01-21
DE69632034D1 (de) 2004-05-06
ATE262907T1 (de) 2004-04-15
NO973612L (no) 1997-09-26
CN1179718A (zh) 1998-04-22
DE69632034T2 (de) 2004-10-14
AU4682196A (en) 1996-08-27
NO973612D0 (no) 1997-08-05
AU716809B2 (en) 2000-03-09
MY119365A (en) 2005-05-31
YU7296A (sh) 1998-08-14
EP0809498B1 (en) 2004-03-31
KR100431042B1 (ko) 2004-06-16
DE69637828D1 (de) 2009-03-12
ATE421358T1 (de) 2009-02-15
MA23800A1 (fr) 1996-10-01
PT809498E (pt) 2004-06-30
KR19980701959A (ko) 1998-06-25
USRE39264E1 (en) 2006-09-05
NZ301407A (en) 1999-01-28

Similar Documents

Publication Publication Date Title
HK1004368A1 (en) Pharmaceutical composition for topical application containing acyclovir and hydrocortisone
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
HUP9900801A3 (en) Corticosteroid-containing pharmaceutical composition
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
IL116455A0 (en) Imidazole compounds and pharmaceutical compositions containing them
HU9601698D0 (en) Pharmaceutical composition
AUPN411195A0 (en) Medicinal composition
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU6015796A (en) Fused imidazole derivatives and medicinal composition thereof
GB9519667D0 (en) Pharmaceutical composition
AU5644196A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
HUP9801158A3 (en) Imidazole derivatives and medicinal composition thereof
HU9500386D0 (en) Benzodiazepine derivatives and pharmaceutical compositions containing them
GB9502695D0 (en) Pharmaceutical composition
ZA9610426B (en) Pharmaceutical composition
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
HUP9602223A2 (en) Biotin derivatives and pharmaceutical compositions containing them
AU3710695A (en) Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
IL117618A0 (en) Diphenylmethyl-azetidinone derivatives and pharmaceutical compositions containing the same
IL117155A0 (en) Quinolizinone derivatives and pharmaceutical compositions containing the same
HUP9802072A3 (en) Benzothiopyranoindazole derivatives and pharmaceutical compositions containing them
HU9602822D0 (en) Pharmaceutical composition
HUP9602732A3 (en) Pharmaceutical composition comprising lanperisone
ZA95736B (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: MEDIVIR AB

Free format text: FORMER OWNER(S): ASTRA AKTIEBOLAG

PF Patent in force
PE Patent expired

Effective date: 20160201